Cocrystal Pharma, Inc. (COCP) DCF Valuation

Cocrystal Pharma, Inc. (COCP) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
Cocrystal Pharma, Inc. (COCP) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Cocrystal Pharma, Inc. (COCP) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Maximize efficiency and improve precision with our (COCP) DCF Calculator! Utilizing actual data from Cocrystal Pharma, Inc. and customizable assumptions, this tool enables you to project, assess, and value (COCP) just like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 6.6 2.0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -69.32 -100 0 0 -42.33 -42.33 -42.33 -42.33 -42.33
EBITDA -47.9 -9.3 -13.8 -38.4 -19.4 .0 .0 .0 .0 .0
EBITDA, % -729.68 -461.97 100 100 100 20 20 20 20 20
Depreciation .3 .3 .4 .4 -1.4 .0 .0 .0 .0 .0
Depreciation, % 3.87 16.68 100 100 100 64.11 64.11 64.11 64.11 64.11
EBIT -48.2 -9.6 -14.2 -38.8 -18.0 .0 .0 .0 .0 .0
EBIT, % -733.55 -478.65 100 100 100 20 20 20 20 20
Total Cash 7.4 33.0 58.7 37.1 26.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .6 .6 .0 .7 .9
Account Receivables, % 9.81 27.61 100 100 100
Inventories .1 .1 .0 .1 .0 .0 .0 .0 .0 .0
Inventories, % 0.76173 2.48 100 100 100 60.65 60.65 60.65 60.65 60.65
Accounts Payable 1.5 .7 .6 .6 1.2 .0 .0 .0 .0 .0
Accounts Payable, % 23.02 32.62 100 100 100 71.13 71.13 71.13 71.13 71.13
Capital Expenditure -.1 -.2 -.1 -.1 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % -2.21 -11.92 100 100 100 -2.83 -2.83 -2.83 -2.83 -2.83
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -48.2 -9.6 -14.2 -38.8 -18.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -47.2 -10.3 -13.3 -39.3 -19.0 -.3 .0 .0 .0 .0
WACC, % 10.87 10.87 10.87 10.87 10.87 10.87 10.87 10.87 10.87 10.87
PV UFCF
SUM PV UFCF -.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -25
Equity Value 24
Diluted Shares Outstanding, MM 10
Equity Value Per Share 2.51

What You Will Receive

  • Pre-Filled Financial Model: Cocrystal Pharma's actual data allows for accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
  • Instantaneous Calculations: Automatic updates provide immediate results as you make adjustments.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
  • Customizable and Reusable: Designed for versatility, enabling repeated use for in-depth forecasts.

Key Features

  • 🔍 Real-Life COCP Financials: Pre-filled historical and projected data for Cocrystal Pharma, Inc. (COCP).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Cocrystal Pharma’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Cocrystal Pharma’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Cocrystal Pharma, Inc.’s (COCP) preloaded data.
  • 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures.
  • 3. Instant Results: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to understand different valuation scenarios.
  • 5. Present with Assurance: Share professional valuation insights to reinforce your strategic decisions.

Why Choose This Calculator for Cocrystal Pharma, Inc. (COCP)?

  • Comprehensive Tool: Combines DCF, WACC, and financial ratio analyses tailored for Cocrystal Pharma.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically computes Cocrystal Pharma’s intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and consultants focused on biotech sectors.

Who Should Use This Product?

  • Individual Investors: Make informed decisions regarding investments in Cocrystal Pharma, Inc. (COCP).
  • Financial Analysts: Enhance valuation methodologies with comprehensive financial models tailored for Cocrystal Pharma, Inc. (COCP).
  • Consultants: Provide clients with accurate and timely valuation insights related to Cocrystal Pharma, Inc. (COCP).
  • Business Owners: Gain insights into the valuation of biotech firms like Cocrystal Pharma, Inc. (COCP) to inform your strategic planning.
  • Finance Students: Explore real-world valuation techniques using data and scenarios from Cocrystal Pharma, Inc. (COCP).

What the Template Contains

  • Historical Data: Includes Cocrystal Pharma’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Cocrystal Pharma’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Cocrystal Pharma’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.